These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 8450427)

  • 21. Dissolution of theophylline from film-coated slow release mini-tablets in various dissolution media.
    Fassihi AR; Munday DL
    J Pharm Pharmacol; 1989 Jun; 41(6):369-72. PubMed ID: 2570830
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of added alkalizer and surfactant on dissolution and absorption of the potassium salt of a weakly basic poorly water-soluble drug.
    Mahjour M; Kesisoglou F; Cruanes M; Xu W; Zhang D; Maguire TJ; Rosen LA; Templeton AC; Kress MH
    J Pharm Sci; 2014 Jun; 103(6):1811-8. PubMed ID: 24788413
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Interactions between a poorly soluble cationic drug and sodium dodecyl sulfate in dissolution medium and their impact on in vitro dissolution behavior.
    Huang Z; Parikh S; Fish WP
    Int J Pharm; 2018 Jan; 535(1-2):350-359. PubMed ID: 29104060
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Release characteristics and in vitro-in vivo correlation of pulsatile pattern for a pulsatile drug delivery system activated by membrane rupture via osmotic pressure and swelling.
    Lin HL; Lin SY; Lin YK; Ho HO; Lo YW; Sheu MT
    Eur J Pharm Biopharm; 2008 Sep; 70(1):289-301. PubMed ID: 18539015
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of Coadministered Water on the In Vivo Performance of Oral Formulations Containing N-Acetylcysteine: An In Vitro Approach Using the Dynamic Open Flow-Through Test Apparatus.
    Sager M; Schneider F; Jedamzik P; Wiedmann M; Schremmer E; Koziolek M; Weitschies W
    Mol Pharm; 2017 Dec; 14(12):4272-4280. PubMed ID: 29064257
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Diclofenac sodium multisource prolonged release tablets--a comparative study on the dissolution profiles.
    Bertocchi P; Antoniella E; Valvo L; Alimonti S; Memoli A
    J Pharm Biomed Anal; 2005 Apr; 37(4):679-85. PubMed ID: 15797788
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Delayed release film coating applications on oral solid dosage forms of proton pump inhibitors: case studies.
    Missaghi S; Young C; Fegely K; Rajabi-Siahboomi AR
    Drug Dev Ind Pharm; 2010 Feb; 36(2):180-9. PubMed ID: 20070183
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Influence of Drug Properties and Formulation on In Vitro Drug Release and Biowaiver Regulation of Oral Extended Release Dosage Forms.
    Lin Z; Zhou D; Hoag S; Qiu Y
    AAPS J; 2016 Mar; 18(2):333-45. PubMed ID: 26769249
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Understanding the in vivo performance of enteric coated tablets using an in vitro-in silico-in vivo approach: case example diclofenac.
    Kambayashi A; Blume H; Dressman J
    Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):1337-47. PubMed ID: 24056057
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Folic acid: a biopharmaceutical evaluation.
    Bellavinha KR; Silva-Barcellos NM; Souza JB; Leite JC; Souza Jd
    Pharm Dev Technol; 2015; 20(6):730-7. PubMed ID: 24867254
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Quality and In-Use Stability Comparison of Brand and Generics of Extended-Release Phenytoin Sodium Capsules.
    Dharani S; Barakh Ali SF; Afrooz H; Bhattacharya R; Khan MA; Rahman Z
    J Pharm Sci; 2019 May; 108(5):1808-1817. PubMed ID: 30611751
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Enhancing Oil Solubility of BCS Class II Drug Phenytoin Through Hydrophobic Ion Pairing to Enable High Drug Load in Injectable Nanoemulsion to Prevent Precipitation at Physiological pH With a Potential to Prevent Phlebitis.
    Modi D; Jonnalagadda S; Campbell GA; Dalwadi G
    J Pharm Sci; 2023 Sep; 112(9):2427-2443. PubMed ID: 36958691
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of lipid and cellulose based matrix former on the release of highly soluble drug from extruded/spheronized, sintered and compacted pellets.
    Maboos M; Yousuf RI; Shoaib MH; Nasiri I; Hussain T; Ahmed HF; Iffat W
    Lipids Health Dis; 2018 Jun; 17(1):136. PubMed ID: 29885655
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Preparation of an amorphous sodium furosemide salt improves solubility and dissolution rate and leads to a faster Tmax after oral dosing to rats.
    Nielsen LH; Gordon S; Holm R; Selen A; Rades T; Müllertz A
    Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):942-51. PubMed ID: 24075980
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A novel asymmetric membrane osmotic pump capsule with in situ formed delivery orifices for controlled release of gliclazide solid dispersion system.
    Yang Y; Zhao Z; Wang Y; Yang L; Liu D; Yang X; Pan W
    Int J Pharm; 2016 Jun; 506(1-2):340-50. PubMed ID: 27132166
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Peroral sustained-release film-coated pellets as a means to overcome physicochemical and biological drug-related problems. I. In vitro development and evaluation.
    Amighi K; Timmermans J; Puigdevall J; Baltes E; Moës AJ
    Drug Dev Ind Pharm; 1998 Jun; 24(6):509-15. PubMed ID: 9876616
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dissolution parameters for sodium diclofenac-containing hypromellose matrix tablet.
    Mourão SC; da Silva C; Bresolin TM; Serra CH; Porta V
    Int J Pharm; 2010 Feb; 386(1-2):201-7. PubMed ID: 19941944
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In vitro dissolution and in vivo oral absorption of methylphenidate from a bimodal release formulation in healthy volunteers.
    Wang Y; Lee L; Somma R; Thompson G; Bakhtiar R; Lee J; Rekhi GS; Lau H; Sedek G; Hossain M
    Biopharm Drug Dispos; 2004 Mar; 25(2):91-8. PubMed ID: 14872557
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Investigation of solubility and dissolution of a free base and two different salt forms as a function of pH.
    Li S; Wong S; Sethia S; Almoazen H; Joshi YM; Serajuddin AT
    Pharm Res; 2005 Apr; 22(4):628-35. PubMed ID: 15846471
    [TBL] [Abstract][Full Text] [Related]  

  • 40. pH- and flow-rate-independent release of drug from uncoated slow-release tablets.
    Jambhekar SS; Cobby J
    J Pharm Sci; 1985 Sep; 74(9):991-4. PubMed ID: 4067855
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.